BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27677707)

  • 1. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
    Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
    Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
    Macedo FI; Mittal VK
    Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.
    Lee SG; Lee J; Kim MJ; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
    Surg Endosc; 2016 Aug; 30(8):3474-9. PubMed ID: 26514137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
    Yan L; Zhang M; Song Q; Luo Y
    Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
    [No Abstract]   [Full Text] [Related]  

  • 7. Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.
    Zhao H; Cui L
    Front Endocrinol (Lausanne); 2021; 12():655608. PubMed ID: 34220708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
    Lee J; Park JH; Lee CR; Chung WY; Park CS
    Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching.
    Tae K; Song CM; Ji YB; Sung ES; Jeong JH; Kim DS
    Surg Endosc; 2016 Nov; 30(11):4785-4792. PubMed ID: 26895921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
    Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
    J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
    Matsuura D; Yuan A; Harris V; Shaha AR; Tuttle RM; Patel SG; Shah JP; Ganly I
    Thyroid; 2022 Jan; 32(1):28-36. PubMed ID: 34861772
    [No Abstract]   [Full Text] [Related]  

  • 12. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Fadda G; Pontecorvi A; Bellantone R
    Endocrine; 2021 May; 72(2):437-444. PubMed ID: 32820358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
    Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer.
    Di Filippo L; Giugliano G; Tagliabue M; Gandini S; Sileo F; Allora A; Grosso E; Proh M; Basso V; Scaglione D; Manzoni MF; Ansarin M
    Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):254-261. PubMed ID: 33100336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
    Lang BH; Wong CKH
    Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
    Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
    Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
    Zhao H; Gong Y
    Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.